Published

Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: European Psychiatry
Date: 2025-04-01
Source: OpenAlex
DOI: 10.1192/j.eurpsy.2025.393
PubMed: Unavailable

Authors

Ioana A. Cristea G Tomei Jazmín Freddi A. Bonessio

Watch author

Derived topics and classifications

psilocybin Clinical Trial Randomized Controlled Trial Review Article Observational Study Safety Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders2025-04-01

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 The trials of translating psilocybin treatment from research to practice.Nature medicine · 2026-08-21 Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06